BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

794 related articles for article (PubMed ID: 17692804)

  • 21. CD40 regulates the processing of NF-kappaB2 p100 to p52.
    Coope HJ; Atkinson PG; Huhse B; Belich M; Janzen J; Holman MJ; Klaus GG; Johnston LH; Ley SC
    EMBO J; 2002 Oct; 21(20):5375-85. PubMed ID: 12374738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma.
    Rossi D; Deaglio S; Dominguez-Sola D; Rasi S; Vaisitti T; Agostinelli C; Spina V; Bruscaggin A; Monti S; Cerri M; Cresta S; Fangazio M; Arcaini L; Lucioni M; Marasca R; Thieblemont C; Capello D; Facchetti F; Kwee I; Pileri SA; Foà R; Bertoni F; Dalla-Favera R; Pasqualucci L; Gaidano G
    Blood; 2011 Nov; 118(18):4930-4. PubMed ID: 21881048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TACI induces cIAP1-mediated ubiquitination of NIK by TRAF2 and TANK to limit non-canonical NF-kappaB signaling.
    Kanno Y; Sakurai D; Hase H; Kojima H; Kobata T
    J Recept Signal Transduct Res; 2010 Apr; 30(2):121-32. PubMed ID: 20184394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deletion of cIAP1 and cIAP2 in murine B lymphocytes constitutively activates cell survival pathways and inactivates the germinal center response.
    Gardam S; Turner VM; Anderton H; Limaye S; Basten A; Koentgen F; Vaux DL; Silke J; Brink R
    Blood; 2011 Apr; 117(15):4041-51. PubMed ID: 21300983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TRAF3 controls activation of the canonical and alternative NFkappaB by the lymphotoxin beta receptor.
    Bista P; Zeng W; Ryan S; Bailly V; Browning JL; Lukashev ME
    J Biol Chem; 2010 Apr; 285(17):12971-8. PubMed ID: 20185819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NIK and IKKbeta interdependence in NF-kappaB signalling--flux analysis of regulation through metabolites.
    Kim HB; Evans I; Smallwood R; Holcombe M; Qwarnstrom EE
    Biosystems; 2010 Feb; 99(2):140-9. PubMed ID: 19909783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequent engagement of RelB activation is critical for cell survival in multiple myeloma.
    Cormier F; Monjanel H; Fabre C; Billot K; Sapharikas E; Chereau F; Bordereaux D; Molina TJ; Avet-Loiseau H; Baud V
    PLoS One; 2013; 8(3):e59127. PubMed ID: 23555623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular inhibitors of apoptosis are global regulators of NF-κB and MAPK activation by members of the TNF family of receptors.
    Varfolomeev E; Goncharov T; Maecker H; Zobel K; Kömüves LG; Deshayes K; Vucic D
    Sci Signal; 2012 Mar; 5(216):ra22. PubMed ID: 22434933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroadaptations in human chronic alcoholics: dysregulation of the NF-kappaB system.
    Okvist A; Johansson S; Kuzmin A; Bazov I; Merino-Martinez R; Ponomarev I; Mayfield RD; Harris RA; Sheedy D; Garrick T; Harper C; Hurd YL; Terenius L; Ekström TJ; Bakalkin G; Yakovleva T
    PLoS One; 2007 Sep; 2(9):e930. PubMed ID: 17895971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of activity and function of the p52 NF-κB subunit following DNA damage.
    Barré B; Coqueret O; Perkins ND
    Cell Cycle; 2010 Dec; 9(24):4795-804. PubMed ID: 21131783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-canonical NFκB mutations reinforce pro-survival TNF response in multiple myeloma through an autoregulatory RelB:p50 NFκB pathway.
    Roy P; Mukherjee T; Chatterjee B; Vijayaragavan B; Banoth B; Basak S
    Oncogene; 2017 Mar; 36(10):1417-1429. PubMed ID: 27641334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Notch3 and pre-TCR interaction unveils distinct NF-kappaB pathways in T-cell development and leukemia.
    Vacca A; Felli MP; Palermo R; Di Mario G; Calce A; Di Giovine M; Frati L; Gulino A; Screpanti I
    EMBO J; 2006 Mar; 25(5):1000-8. PubMed ID: 16498412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Negative regulation of JNK signaling by the tumor suppressor CYLD.
    Reiley W; Zhang M; Sun SC
    J Biol Chem; 2004 Dec; 279(53):55161-7. PubMed ID: 15496400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NF-kappaB is essential for induction of CYLD, the negative regulator of NF-kappaB: evidence for a novel inducible autoregulatory feedback pathway.
    Jono H; Lim JH; Chen LF; Xu H; Trompouki E; Pan ZK; Mosialos G; Li JD
    J Biol Chem; 2004 Aug; 279(35):36171-4. PubMed ID: 15226292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling.
    Vallabhapurapu S; Matsuzawa A; Zhang W; Tseng PH; Keats JJ; Wang H; Vignali DA; Bergsagel PL; Karin M
    Nat Immunol; 2008 Dec; 9(12):1364-70. PubMed ID: 18997792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.
    Tse AK; Wan CK; Shen XL; Yang M; Fong WF
    Biochem Pharmacol; 2005 Nov; 70(10):1443-57. PubMed ID: 16181613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A cytoplasmic ATM-TRAF6-cIAP1 module links nuclear DNA damage signaling to ubiquitin-mediated NF-κB activation.
    Hinz M; Stilmann M; Arslan SÇ; Khanna KK; Dittmar G; Scheidereit C
    Mol Cell; 2010 Oct; 40(1):63-74. PubMed ID: 20932475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct inhibition of elastase activity by indole-3-carbinol triggers a CD40-TRAF regulatory cascade that disrupts NF-kappaB transcriptional activity in human breast cancer cells.
    Aronchik I; Bjeldanes LF; Firestone GL
    Cancer Res; 2010 Jun; 70(12):4961-71. PubMed ID: 20530686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of noncanonical NF-kappaB signaling by the oncoprotein Tio.
    de Jong SJ; Albrecht JC; Schmidt M; Müller-Fleckenstein I; Biesinger B
    J Biol Chem; 2010 May; 285(22):16495-503. PubMed ID: 20353939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional interplay between NF-κB-inducing kinase and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma.
    Mazzera L; Abeltino M; Lombardi G; Cantoni AM; Ria R; Ricca M; Saltarella I; Naponelli V; Rizzi FMA; Perris R; Corradi A; Vacca A; Bonati A; Lunghi P
    Haematologica; 2019 Dec; 104(12):2465-2481. PubMed ID: 30948493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.